Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502240777

Apexbio Technology LLC Chlorzoxazone 95-25-0 5g
SDP

Catalog No. 502240777
Encompass_Preferred

Chlorzoxazone (CAS 95-25-0) is a small molecule that functions as a centrally acting skeletal muscle relaxant It exerts its pharmacological effects by modulating synaptic transmission within the spinal cord resulting in reduced muscle spasticity In biomedical research chlorzoxazone is frequently employed as a selective probe substrate for cytochrome P450 2E1 (CYP2E1) in human liver microsomes facilitating the assessment of hepatic CYP2E1 activity and drug metabolism This compound is valuable for investigating drug-drug interactions and metabolic profiling involving CYP2E1

This item is not returnable. View return policy
Catalog No. 50-224-0777 Supplier Apexbio Technology LLC Supplier No. B17015000
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Chlorzoxazone (CAS 95-25-0) is a small molecule that functions as a centrally acting skeletal muscle relaxant It exerts its pharmacological effects by modulating synaptic transmission within the spinal cord resulting in reduced muscle spasticity In biomedical research chlorzoxazone is frequently employed as a selective probe substrate for cytochrome P450 2E1 (CYP2E1) in human liver microsomes facilitating the assessment of hepatic CYP2E1 activity and drug metabolism This compound is valuable for investigating drug-drug interactions and metabolic profiling involving CYP2E1

This item is not returnable. View return policy
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.